These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6877073)

  • 1. [Galactose elimination capacity--conclusiveness and clinical importance].
    Kuntz HD; May B
    Med Welt; 1983 Jun; 34(22):646-8. PubMed ID: 6877073
    [No Abstract]   [Full Text] [Related]  

  • 2. The hepatic galactose elimination capacity measured after a single intravenous injection of galactose in normal adults and in patients with various liver diseases.
    den Blaauwen DH; Thijs LG
    Neth J Med; 1973; 16(1):2-13. PubMed ID: 4696952
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatic metabolic clearance with galactose].
    Galea G; Sdrobici D; Niţu V; Enache C
    Med Interna (Bucur); 1970 Sep; 22(9):1051-6. PubMed ID: 5491374
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intravenous loading with galactose as a liver function test. Methods and clinical value].
    Kuntz HD; Kuntz E
    Fortschr Med; 1983 Jun; 101(21):999-1004. PubMed ID: 6873856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
    Lindskov J
    Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic clearance by the hepatic cells].
    Takamori S
    Nihon Rinsho; 1979 Jun; Suppl():2346-9. PubMed ID: 491151
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats.
    Young TH; Tang HS; Lee HS; Hsiong CH; Hu OY
    Metabolism; 2007 Sep; 56(9):1265-9. PubMed ID: 17697871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death.
    Merkel C; Marchesini G; Fabbri A; Bianco S; Bianchi G; Enzo E; Sacerdoti D; Zoli M; Gatta A
    Hepatology; 1996 Oct; 24(4):820-3. PubMed ID: 8855183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified method to determine galactose elimination capacity in patients with liver disease.
    Bergström M; Söderman C; Eriksson LS
    Scand J Clin Lab Invest; 1993 Nov; 53(7):667-70. PubMed ID: 8272755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The galactose eliminating capacity of the liver and its protein synthesis function in chronic liver diseases].
    Kupcová V; Turecký L; Brixová E
    Bratisl Lek Listy; 1994 Sep; 95(9):395-401. PubMed ID: 7812845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver.
    Ballmer PE; Reichen J; McNurlan MA; Sterchi AB; Anderson SE; Garlick PJ
    Hepatology; 1996 Jul; 24(1):53-9. PubMed ID: 8707282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analog computer analysis of intestinal absorption as shown on galactose absorption].
    Rommel K
    Verh Dtsch Ges Pathol; 1969; 53():158-61. PubMed ID: 4190707
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent aspects of liver biochemistry: from physiopathology to functional liver exploration].
    Guéchot J; Gerhardt M; Imbert-Bismut F; Jezequel-Cuer M; Myara A; Vassault A; Vaubourdolle M; Voitot H
    Ann Biol Clin (Paris); 1995; 53(7-8):373-94. PubMed ID: 8597308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ethanol and diabetes on galactose oxidative metabolism and elimination in rats.
    Mion F; Géloën A; Minaire Y
    Can J Physiol Pharmacol; 1999 Mar; 77(3):182-7. PubMed ID: 10535691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the hepatic elimination capacity (Lm) of galactose by single injection.
    Tygstrup N
    Scand J Clin Lab Invest Suppl; 1966; 18():118-25. PubMed ID: 5958511
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic galactose elimination kinetics in the intact pig.
    Keiding S; Johansen S; Winkler K
    Scand J Clin Lab Invest; 1982 May; 42(3):253-9. PubMed ID: 7134810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-order clearance of plasma galactose: the effect of liver disease.
    Henderson JM; Kutner MH; Bain RP
    Gastroenterology; 1982 Nov; 83(5):1090-6. PubMed ID: 7117792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carbohydrate metabolism and study of liver function].
    Bianco C; Bonsi R; Papotti G
    Arch Sci Med (Torino); 1967 Oct; 124(4):411-22. PubMed ID: 5592902
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged digoxin elimination in two patients with renal and hepatic disease.
    Sorkness R
    Clin Pharm; 1983; 2(3):271-3. PubMed ID: 6883956
    [No Abstract]   [Full Text] [Related]  

  • 20. [15N liver function test in underweight infants, hypotrophic at birth].
    Richter T; Krumbiegel P; Beyreiss K
    Kinderarztl Prax; 1993 Dec; 61(10):365-9. PubMed ID: 8145453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.